Sort Through Options for ESBL, CRE, and Resistant Pseudomonas

November 2020

We're getting questions about how to treat multidrug-resistant (MDR) gram-negative infections.

These infections are often caused by extended-spectrum beta-lactamase (ESBL) producers...carbapenem-resistant Enterobacterales (CRE)...or Pseudomonas with "difficult-to-treat resistance" (DTR).

Be ready to answer questions and work with your ID team.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Infectious Diseases Answer Questions About Using Steroids for COVID-19
Hemorrhage Optimize Safe Use of IV Tranexamic Acid
Infectious Diseases Sort Through Options for ESBL, CRE, and Resistant Pseudomonas
Nausea & Vomiting Combine Antiemetics and Peri-Op Strategies for PONV Prophylaxis
Practice Explain Limitations of COVID-19 Antibody Testing
Asthma Describe the Role of Trelegy and Triple Therapy for Asthma
Practice Evaluate if Guideline Recommendations "Fit" Your Patients
Med Administration Share Tips About Cutting, Crushing, or Giving Meds Via Tubes
Fever Improve Accuracy of Noncontact Infrared Thermometers

Sort Through Options for ESBL, CRE, and Resistant Pseudomonas

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents